论文部分内容阅读
目的:分析个体化期待治疗对中央性前置胎盘的疗效。方法:选取2010年1月—2011年10月住院收治的中央性前置胎盘患者78例,将期待治疗方案的39例设为观察组,常规治疗方案的39例设为对照组,观察终止妊娠时间、产后出血量、产后感染、婴儿体重、Apgar评分、病死率、呼吸窘迫综合征(RDS)项目。结果:采用个体化期待治疗的观察组分娩时孕周、婴儿体重、新生儿Apgar评分均明显大于对照组,差异有统计学意义(P<0.01)。而观察组产后出血量、RDS发生率均明显少于对照组,差异有统计学意义(P<0.01)。观察组产褥感染率(2.6%)与对照组(10.3%)差异无统计学意义(P>0.05)。结论:对于B超检查的中央性前置胎盘患者中,无致命性活动性阴道出血者,可选择个体化有针对性的期待治疗方案,可有效减少产妇和新生儿并发症的发生。
Objective: To analyze the effect of individualized expectant treatment on central placenta previa. Methods: From January 2010 to October 2011, 78 patients with central placenta accreta admitted to hospital were enrolled, 39 patients were expected to treat the treatment group as the observation group, 39 cases of conventional treatment as the control group, observe the termination of pregnancy Time, postpartum hemorrhage, postnatal infection, infant weight, Apgar score, case fatality rate, respiratory distress syndrome (RDS) program. Results: The gestational age, infant weight and neonatal Apgar score in observation group with individualized expectant treatment were significantly higher than those in control group with statistical significance (P <0.01). The observation group postpartum hemorrhage, RDS incidence was significantly less than the control group, the difference was statistically significant (P <0.01). The rate of puerperal infection in observation group (2.6%) was not significantly different from that in control group (10.3%) (P> 0.05). Conclusion: For those patients with central placenta previa who underwent B-ultrasound who have no life-threatening vaginal bleeding, they can choose individualized and targeted expectant treatment to reduce the incidence of maternal and neonatal complications.